Skip to main content

Health

More in Health

Pediatric OncologyExplainer

Landmark Trial: Immunotherapy Achieves 96% Disease-Free Survival in Children's Most Common Cancer

Clinical Researchers 40%Health Economists 30%Patient Advocates 30%

6 sources · 64d ago

ExplainerBrain Stimulation

Landmark Trial: Non-Invasive Focused Ultrasound Modulates Amygdala, Halving Symptoms in Depression and Anxiety

Clinical Researchers 40%Psychiatric Practitioners 35%Patient Advocates 25%

4 sources · 66d ago

ExplainerEndometriosis

Landmark Trial Finds Dichloroacetate (DCA) Halves Pain in Endometriosis, Offering First Non-Hormonal Treatment

Clinical Researchers 44%Patient Care Advocates 33%Global Health Authorities 22%

7 sources · 66d ago

Sleep ScienceExplainer

Sleep Duration Emerges as Stronger Predictor of Longevity Than Diet or Exercise in Landmark Study

Sleep Physiologists 40%Public Health Officials 30%Longevity Advocates 30%

3 sources · 66d ago

Research BriefOncology Breakthrough

Landmark Trial Adds Immunotherapy to Chemo, Halving Recurrence Risk in Stage III dMMR Colon Cancer

Clinical Oncologists 40%Patient Advocacy Groups 30%Regulatory & Industry Analysts 30%

5 sources · 66d ago

Integrative CareExplainer

WHO Adopts Landmark 10-Year Strategy to Integrate Traditional and Complementary Medicine into Global Health Systems

Integrative Health Advocates 40%Scientific Skeptics 30%Global South Policymakers 30%

3 sources · 66d ago

Thyroid Eye DiseaseExplainer

FDA Approves Lumvoa, First IGF-1R Inhibitor to Treat Thyroid Eye Disease

Clinical Ophthalmologists 35%Patient Advocacy Groups 35%Industry Analysts 30%

5 sources · 66d ago

ExplainerBrain Stimulation

Landmark Case: Personalized Deep Brain Stimulation Achieves Rapid Symptom Reduction in Severe Treatment-Resistant OCD

Neuromodulation Researchers 40%Clinical Psychiatrists 35%Patient Advocacy Groups 25%

5 sources · 66d ago

ExplainerPsychedelic Medicine

Single-Dose Psilocybin Therapy Achieves Rapid Reduction in Chronic Suicidal Ideation in Landmark Trial

Psychiatric Researchers 40%Clinical Implementers 30%Patient Advocates 30%

4 sources · 66d ago

ExplainerIgA Nephropathy

How VOYXACT's APRIL Inhibition is Stabilizing Kidney Function in IgA Nephropathy

Clinical Researchers 40%Regulatory & Medical Consensus 35%Biopharma Developers 25%

3 sources · 67d ago

ExplainerHER2 Therapies

FDA Approves T-DXd for Early-Stage HER2+ Breast Cancer, Signaling New Standard of Care

Clinical Researchers 47%Regulatory Monitors 35%Industry Analysts 18%

5 sources · 67d ago